Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IGC Pharma (IGC) Gross Profit (2016 - 2025)

Historic Gross Profit for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $99000.0.

  • Pharma's Gross Profit fell 5000.0% to $99000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $511000.0, marking a year-over-year decrease of 2315.79%. This contributed to the annual value of $619000.0 for FY2025, which is 1555.25% down from last year.
  • Per Pharma's latest filing, its Gross Profit stood at $99000.0 for Q3 2025, which was down 5000.0% from $154000.0 recorded in Q2 2025.
  • In the past 5 years, Pharma's Gross Profit registered a high of $255000.0 during Q2 2023, and its lowest value of $26000.0 during Q2 2021.
  • Its 5-year average for Gross Profit is $119368.4, with a median of $133000.0 in 2023.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 44615.38% in 2022, then plummeted by 5000.0% in 2025.
  • Quarter analysis of 5 years shows Pharma's Gross Profit stood at $62000.0 in 2021, then surged by 64.52% to $102000.0 in 2022, then soared by 30.39% to $133000.0 in 2023, then fell by 21.8% to $104000.0 in 2024, then decreased by 4.81% to $99000.0 in 2025.
  • Its Gross Profit stands at $99000.0 for Q3 2025, versus $154000.0 for Q2 2025 and $154000.0 for Q1 2025.